Debut Plus

34.9

+0.12 +0.35%

As of 10 Sept 2026 · delayed

NSE Listed

Fischer Medical Venture Limited (FISCHER)

Volume: 4,51,549Avg Vol 1W: 4,00,276.8Avg Vol 1M: 7,48,364.152W Range:31.05124.7
Key Ratios
Checked 5h ago
Market Cap₹2,430 Cr
Current Price₹34.9
Previous Close₹34.78
High / Low (52w)₹124.7 / ₹31.05
Volume4,51,549
Avg Vol (1W)4,00,276.8
Avg Vol (1M)7,48,364.1
Stock P/E8,977
Book Value₹47.88
Dividend Yield
ROE0.3%
ROA
Revenue (TTM)₹112 Cr
Revenue Growth
Profit Margin
Total Debt₹0 Cr
Shares Outstanding
Face Value₹1
EPS (TTM)₹0.1
P/B18.75
Debt / Equity0.05
50 DMA₹37.65
200 DMA₹38.36
Day change+0.35%
Price Chart
34.9 69.94% · 1Y
118311.6Cr
2025-09-10
2026-09-10

20-day avg volume: 7.5L shares

Pros
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 8977.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹40 Cr₹12 Cr₹49 Cr₹23 Cr₹86 Cr₹101 Cr₹98 Cr₹82 Cr
EBITDA₹0 Cr₹0 Cr₹2 Cr₹11 Cr₹18 Cr₹22 Cr₹-4 Cr₹11 Cr
Net Profit₹0 Cr₹0 Cr₹1 Cr₹5 Cr₹14 Cr₹19 Cr₹-12 Cr₹4 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹0 Cr₹5 Cr₹112 Cr₹5 Cr₹7 Cr₹1 Cr₹4 Cr₹1 Cr
EBITDA₹1 Cr₹-1 Cr₹3 Cr₹1 Cr₹3 Cr₹-1 Cr₹-9 Cr₹-2 Cr
Net Profit₹0 Cr₹-1 Cr₹1 Cr₹-1 Cr₹1 Cr₹-2 Cr₹-9 Cr₹-3 Cr
EPS0.08
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹86 Cr₹457 Cr
Total Liabilities₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹5 Cr₹120 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹81 Cr₹338 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹-7 Cr₹-86 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹-31 Cr₹-125 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹37 Cr₹315 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-7 Cr₹-86 Cr
Shareholding
Promoter 63.08% Institutions 6.83% Public 30.09%
Efficiency & Working Capital
ROCE10.6%
Interest Coverage5.5
Dividend Payout
Debtor Days251 d
Inventory Days30 d
Payable Days68 d
Cash Conversion Cycle213 d
Working Capital Days281 d
Shareholding Details

As of 2026-08-31

Promoter63.1%
FII5.6%
DII1.3%
Institutions6.8%
Public30.1%
Promoter Pledge6.8%
No. of Shareholders23,951
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodFeb 2025Mar 2025Apr 2025Apr 2025Jun 2025Jul 2025Jul 2025Sept 2025Dec 2025Mar 2026Jun 2026Aug 2026
Promoters62.8%62.8%61.8%61.8%61.8%61.8%61.8%61.8%61.8%62.1%62.1%63.1%
FIIs5.1%5.2%5.4%5.4%5.6%5.6%5.6%5.6%4.9%5%5.5%5.6%
DIIs1.4%1.4%1.4%1.4%1.4%1.4%0%1.4%1.4%1.4%1.3%1.3%
Public30.7%30.5%31.4%31.4%31.2%31.2%32.6%31.2%32%31.5%31%30.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%7.4%7.4%6.8%
No. of Shareholders9,86510,18010,18210,18210,05810,05010,05013,05422,92023,26923,95023,951
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Fmv Holdings Pte LtdShareholding of Promoter and Promoter Group50.8%35.48 Cr
Shankar VaradharajanShareholding of Promoter and Promoter Group12.3%8.60 Cr
Vikasa India Eif I FundPublic Shareholding2.8%1.97 Cr
Roopal Hitesh Kawa .Public Shareholding2.5%1.78 Cr
India Emerging Giants Fund LimitedPublic Shareholding2.3%1.62 Cr
Vinay Rajendrakumar NagdaPublic Shareholding1.4%1.00 Cr
Blue Lotus Capital Multi Bagger Fund IiPublic Shareholding1.3%88,15,820
L7 Hitech Private LimitedPublic Shareholding1.2%81,56,648
Kaushik Hasmukhlal Gandhi .Public Shareholding1.1%79,50,000
Natwarlal Keshavjibhai Kawa .Public Shareholding1.1%77,38,320
Vritti Hitesh KawaPublic Shareholding1%71,70,000
Hitesh Natwarlal Kawa .Public Shareholding1%71,56,790
Nimesh Sahadeo SinghPublic Shareholding1%69,71,530
Ks Smart Technologies LtdShareholding of Promoter and Promoter Group0%0
Ravindran GovindanShareholding of Promoter and Promoter Group0%0
Mercatus Capital Pte LtdShareholding of Promoter and Promoter Group0%0
Time Medical Holdings Company LtdShareholding of Promoter and Promoter Group0%0
Eight Mercatus Pte. LtdShareholding of Promoter and Promoter Group0%0
Neuome Peptides Pte LtdShareholding of Promoter and Promoter Group0%0
Mercatus Medtech Pte LtdShareholding of Promoter and Promoter Group0%0
Infinite Diagnostics Pte LtdShareholding of Promoter and Promoter Group0%0
Eight Mighty Ventures Pte LtdShareholding of Promoter and Promoter Group0%0
Eight Ndx Ventures Pte LtdShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Shankar Varadharajan3.00 Cr34.9%2026-08-21
Board of Directors
NameDesignationYear
RAVINDRAN GOVINDANED / MD / Promoter2025
Svetlana RaoE D & Wholetime Director2025
Sanjay Jayantilal JainIndependent Non Exe. Director2025
Khairy Jamaluddin Abu BakkarIndependent Non Exe. Director2025
Jacob ThomasIndependent Non Exe. Director2025
Roberto M PagdangananIndependent Non Exe. Director2025
JAYA ANKUR SINGHANIAIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10806464
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-22Dividend
forthcoming2026-08-14Board Meetings
dividend2025-09-22₹0.005 (0.5%)Final
split2025-09-121:10face value change from 10 to 1
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20250400517
2025040004
20250000512
Insider / Designated-Person Trades

11 recent disclosure(s)

FMV Holdings Pte LtdAcquisition · 4,54,210
FMV Holdings Pte LtdAcquisition · 73,35,909
Shankar VaradharajanAcquisition · 60,00,000
FMV Holdings Pte LtdAcquisition · 97,78,217
Shankar VaradharajanAcquisition · 15,00,000
FMV Holdings Pte LtdAcquisition · 54,31,664
Substantial Acquisitions (SAST)

5 disclosure(s)

Pref. Allotment17/08/2026 · 4,54,210
Pref. Allotment14/08/2026 · 1,33,35,909
Pref. Allotment13/08/2026 · 1,12,78,217
Pref. Allotment12/8/2026 · 66,31,664
Pref. Allotment11/8/2026 · 23,00,000
Company Information
Incorporated1993
AuditorBilimoria Mehta and Co
Investor Email[email protected]
🌐 www.fischerchemic.in

📍 104 1st Fl Bhhind Poisar Depot, Raghuleela Mall Kandivali (W), Mumbai, Maharashtra, 400067

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search